Further to the announcement dated 4 March 2022, the Board of Directors of Analabs wishes to announce that the Analabs Group had acquired quoted securities in Malayan Banking Berhad (“MBB”) during the period 5 March 2022 to 24 May 2022 for which the aggregate of the purchase consideration amounting to RM21,135,919 (“the Acquisitions”) has exceeded 5% of the Analabs Group’s audited consolidated net assets as at 30 April 2021.
Please refer to the attachment for details of the announcement.
This announcement is dated 24 May 2022